ABSTRACT
Stroke in the cancer patient is most often caused by disorders of coagulation that
are induced by the cancer, by cancer metastatic to the central nervous system, or
by coagulation disorders or vascular injury induced by cancer therapy. Nonbacterial
thrombotic endocarditis with diffuse thrombosis of cerebral vessels is often the cause
of cerebral infarction. Venous occlusion is most common in leukemic patients but can
also result from growth of solid tumor in the adjacent skull or dura. Chemotherapy
administration is associated with a small risk of cerebral arterial or venous thrombosis.
Radiation that is administered to the neck can result in delayed carotid atherosclerosis.
Tumor embolization to the brain is a rare cause of stroke. Fungal septic cerebral
emboli occur most commonly in leukemic patients who have undergone bone marrow transplant.
Hemorrhages occur in the brain parenchyma or subdural space and are most commonly
caused by acute disseminated intravascular coagulation or metastatic tumor. Hemolysis
from chemotherapy administration is a rare cause of brain hemorrhage. Neuroimaging
studies, measurement of coagulation function, and echocardiography are the must useful
modalities to identify the cause of stroke.
KEYWORDS
Coagulopathy - nonbacterial thrombotic endocarditis - disseminated intravascular coagulation
- venous occlusion
REFERENCES
1
Graus F, Rogers L R, Posner J B.
Cerebrovascular complications in patients with cancer.
Medicine.
1985;
64
16-35
2
Chaturvedi S, Ansell J, Recht L.
Should cerebral ischemic events in cancer patients be considered a manifestation of
hypercoagulability?.
Stroke.
1994;
25
1215-1218
3
Cestari D M, Weine D M, Panageas K S, Segal A Z, DeAngelis L M.
Stroke in patients with cancer-incidence and etiology.
Neurology.
2004;
62
2025-2030
4
Lee A Y.
Cancer and thromboembolic disease: pathogenic mechanisms.
Cancer Treat Rev.
2002;
28
137-140
5
Rogers L R, Cho E-S, Kempin S, Posner J B.
Cerebral infarction from non-bacterial thrombotic endocarditis: clinical and pathological
study including the effects of anticoagulation.
Am J Med.
1987;
83
746-756
6
Reisner S A, Brenner B, Haijm N, Edoute Y, Markiewicz W.
Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical
entity.
J Am Soc Echocardiogr.
2000;
13
876-881
7
Reagan T J, Okazaki H.
The thrombotic syndrome associated with carcinoma.
Arch Neurol.
1974;
31
390-395
8
Collins R C, Al-Mondhiry H, Chernik N L, Posner J B.
Neurologic manifestations of intravascular coagulation in patients with cancer.
Neurology.
1975;
25
795-806
9
Raizer J J, DeAngelis L M.
Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients.
Neurology.
2000;
54
1222-1226
10
Murros K E, Toole J F.
The effect of radiation on carotid arteries.
Arch Neurol.
1989;
46
449-455
11
Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner S A.
Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study
of 200 patients.
Am J Med.
1997;
102
252-258
12
Patchell R A, White C L, Clark A W, Beschorner W E, Santos G W.
Nonbacterial thrombotic endocarditis in bone marrow transplant patients.
Cancer.
1985;
55
631-635
13
Masjuan J, Pardo J, Callejo J M, Andres M T, Alvarez-Cermeno J C.
Tamoxifen: a new risk factor for cerebral sinus thrombosis.
Neurology.
2004;
62
334-335
14
Singhal A B, Topcuoglu M A, Buonanno F S.
Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis:
a discussion-weighted magnetic resonance imaging study.
Stroke.
2002;
33
1267-1273
15
Lee A Y, Levine M N, Baker R I et al..
for the Randomized Comparison of Low-Molecular-Weight Heparin Versus Oral Anticoagulant
Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
(CLOT) Investigators. Low molecular-weight heparin versus a coumarin for the prevention
of recurrent venous thromboembolism in patients with cancer.
N Engl J Med.
2003;
349
146-153
16
DeBruijn S F, Budde M, Teunisse S, de Haan R J, Stam J.
Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis.
Neurology.
2000;
54
1687-1689
17
Fink J N, McAuley D L.
Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral
hematoma.
Neurology.
2001;
57
1138-1139
18
Soleau S W, Schmidt R, Stevens S, Osborn A, MacDonald J D.
Extensive experience with dural sinus thrombosis.
Neurosurgery.
2003;
52
534-544
19
Klein P, Haley E C, Wooten G F et al..
Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous
leptomeningeal metastases.
Arch Neurol.
1989;
46
1149-1152
20
Anghel G, Pettinato G, Severino A et al..
Intravascular B-cell lymphoma: report of two cases with different clinical presentation
but rapid central nervous system involvement.
Leuk Lymphoma.
2003;
44
1353-1359
21
Herman C, Kupsky W J, Rogers L, Duman R, Moore P.
Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis: case
report with angiographic and pathological studies.
Stroke.
1995;
26
2366-2370
22
Williams R L, Cidis Meltzer C, Smirniotopoulos J G, Fukui M B, Inman M.
Cerebral MR imaging in intravascular lymphomatosis.
AJNR Am J Neuroradiol.
1998;
19
427-431
23
Matsumoto K, Ohta M, Takeshita I.
Reversible non-thrombotic occlusion of the superior sagittal sinus caused by metastatic
malignant lymphoma: case report.
Neurol Med Chir (Tokyo).
2003;
43
349-351
24
Calamia K T, Miller A, Shuster E A, Perniciaro C, Menke D M.
Intravascular lymphomatosis. A report of ten patients with central nervous system
involvement and a review of the disease process.
Adv Exp Med Biol.
1999;
455
249-265
25
Lee A Y, Levine M N.
The thrombophilic state induced by therapeutic agents in the cancer patient.
Semin Thromb Hemost.
1999;
25
137-145
26
Gugliotta L, Mazucconi M G, Leone G et al..
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia
receiving L-asparaginase during induction therapy: a retrospective study.
Eur J Haematol.
1992;
49
63-66
27
Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Bohles H.
Cerebrovascular complications for L-asparaginase in the therapy of acute lymphoblastic
leukemia.
J Pediatr Hematol Oncol.
2003;
25
484-487
28
Dorresteijn L D, Kappelle A C, Boogerd W et al..
Increased risk of ischemic stroke after radiotherapy on the neck in patients younger
than 60 years.
J Clin Oncol.
2002;
20
282-288
29
Steele S R, Martin M J, Mullenix P S, Crawford J V, Cuadrado D S, Andersen C A.
Focused high-risk population screening for carotid arterial stenosis after radiation
therapy for head and neck cancer.
Am J Surg.
2004;
187
594-598
30
El Amrani M, Heinzlef O, Debroucker T, Roullet E, Bousser M-G, Amarenco P.
Brain infarction following 5-fluorouracil and cisplatin therapy.
Neurology.
1998;
51
899-901
31
Pritchard K I, Paterson A H G, Paul N A, Zee B, Fine S, Pater J.
for the NCI of Canada Clinical Trials Group Breast Cancer Site Group. Increased thromboembolic
complications with concurrent tamoxifen and chemotherapy in a randomized trial of
adjuvant therapy for women with breast cancer.
J Clin Oncol.
1996;
14
2731-2737
32
Lam W W, Leung S F, So N M et al..
Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy.
Cancer.
2001;
92
2357-2363
33
Ito Y, Arahata Y, Goto Y et al..
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.
AJNR Am J Neuroradiol.
1998;
19
415-417
34
Cheng S W K, Wu L L H, Ting A C W, Lau H, Lam L K, Wei W I.
Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies.
Am J Surg.
1999;
178
323-328
35
Kashyap V S, Moore W S, Quinones B, Baldrich W J.
Carotid artery repair for radiation-associated atherosclerosis is a safe and durable
procedure.
J Vasc Surg.
1999;
29
90-96
36
Leseche G, Castier Y, Chataigner O et al..
Carotid artery revascularization through a radiated field.
J Vasc Surg.
2003;
38
244-250
37
O'Neill B P, Dinapoli R P, Okazaki H.
Cerebral infarction as a result of tumor emboli.
Cancer.
1987;
60
90-95
38
Lefkovitz N W, Roessmann U, Kori S H.
Major cerebral infarction from tumor embolus.
Stroke.
1986;
17
555-557
39
Murata J, Sawamura Y, Takahashi A et al..
Intracerebral hemorrhage caused by a neoplastic aneurysm from small-cell lung carcinoma:
case report.
Neurosurgery.
1993;
32
124-126
40
Pickering L, Cox I, Pandha H.
Left atrial sarcoma presenting as cerebral infarction.
Lancet Oncol.
2001;
2
705-706
41
Urrutia V, Jichici D, Thomas C E, Nunes L W, Schwartzman R J.
Embolic stroke secondary to an aortic arch tumor: a case report.
Angiology.
2000;
51
959-962
42
Brown D V, Faber L P, Tuman K J.
Perioperative stroke caused by arterial tumor embolism.
Anesth Analg.
2004;
98
806-809
43
Coplin W M, Cochran M S, Levine S R, Crawford S W.
Stroke after bone marrow transplantation-frequency, aetiology and outcome.
Brain.
2001;
124
1043-1051
44
Kawanami T, Kurita K, Yamakawa M, Omoto E, Kato T.
Cerebrovascular disease in acute leukemia: A clinicopathological study of 14 patients.
Intern Med.
2002;
41
1130-1134
45
Walsh T J, Hier D B, Caplan L R.
Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.
Ann Neurol.
1985;
18
574-582
46
Antman K H, Skarin A T, Mayer R J et al..
Microangiopathic hemolytic anemia and cancer: a review.
Medicine.
1979;
58
377-384
47
Gordon L I, Kwaan H C.
Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic
uremic syndrome in the cancer patient.
Semin Thromb Hemost.
1999;
25
217-221
48
Humphreys B D, Sharman J P, Henderson J M et al..
Gemcitabine-associated thrombotic microangiopathy.
Cancer.
2004;
100
2664-2670
49
Pitner S E, Johnson W W.
Chronic subdural hematoma in childhood acute leukemia.
Cancer.
1973;
32
185-190
50
Jourdan E, Dombret H, Glaisner S, Miclea J M, Castaigne S, Degos L.
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy
for acute myeloid leukaemia with a monoblastic component.
Br J Haematol.
1995;
89
527-530
51
Graus F, Saiz A, Sierra J et al..
Neurologic complications of autologous and allogeneic bone marrow transplantation
in patients with leukemia: a comparative study.
Neurology.
1996;
46
1004-1009
52
Tallman M S, Andersen J W, Schiffer C A et al..
A prospective randomized study of all-trans retinoic acid induction and maintenance
therapy for patients with acute promyelocytic leukemia.
N Engl J Med.
1997;
337
1021-1028
53
Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S.
Diagnosis and management of subdural haematoma complicating bone marrow transplantation.
Bone Marrow Transplant.
2000;
25
549-552
54
Lieu A S, Hwang S L, Howng S L, Chai C Y.
Brain tumors with hemorrhage.
J Formos Med Assoc.
1999;
98
365-367
55
Minette S E, Kimmel D W.
Subdural hematoma in patients with systemic cancer.
Mayo Clin Proc.
1989;
64
637-642
56
McIver J I, Scheithauer B W, Rydberg C H, Atkinson J LD.
Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report.
Neurosurgery.
2001;
49
447-449
57
Wurthner J U, Kohler G, Behringer D, Lindemann A, Mertelsmann R, Lubbert M.
Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in
patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report
of four cases.
Cancer.
1999;
85
368-374
58
Nowacki P, Fryze C, Zdziarska B, Zyluk B, Grzelec H, Dudzik T.
Central nervous system leukostasis in patients with leukemias and lymphomas.
Folia Neuropathol.
1995;
33
59-65
59
McKenzie C R, Rengachary S S, McGregor D H, Dixon A, Suskind D L.
Subdural hematoma associated with metastatic neoplasms.
Neurosurgery.
1990;
27
619-625
60
Bromberg J E, Vandertop W P, Jansen G H.
Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic
leukaemia.
Br J Neurosurg.
1998;
12
373-376
61
Atlas S W, Grossman R I, Gomori J M et al..
Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging.
Radiology.
1987;
164
71-77
Lisa RogersD.O.
Hermelin Brian Tumor Center, Henry Ford Hospital
2799 W Grand Blvd.
Detroit, MI 48202